Silicone Breast Implants Under the Breast Incision in Porto Alegre Brazil
Breast augmentation, or augmentation mammoplasty, is one of the most common plastic surgery procedure performed today. Over time, factors such as age, genetics, pregnancy, weight changes, sun exposure, and gravity can cause the size and shape of the breast to change. Women who are dissatisfied with the size of their breasts, or have experienced changes in breast appearance can achieve a fuller, shapelier breast with breast augmentation. During breast augmentation, a breast implant is placed inside a pocket formed in the breast tissue. This can help to increase or balance the size of the breast, restore breast volume, or restore the shape of the breast after partial or total loss. It is important to realize that breast augmentation cannot correct significantly sagging or drooping breasts. In these instances, a breast lift is often necessary, which may be performed in conjunction with this procedure.
Re-approved by the FDA in 2006, silicone implants are made of a silicone rubber shell and are filled with silicone gel. There is no significant evidence that suggests silicone implants increase your risk for breast cancer, connective tissue disorders, or autoimmune disease. You must be at least 22 years old to receive silicone implants. Breast implants differ by shape, texture, and profile. Breast implants may be round or contoured, and may have a smooth or textured surface. The breast implant profile may be standard, moderate, or high. Lastly, breast implants vary by size, or volume. The type, style, and size of breast implants you choose are determined by your lifestyle, body contours, the amount of breast tissue you have, and the cup size and appearance that you would like to achieve. Be sure to talk with your doctor in depth about choosing the breast implant option that is right for you.
The breast consists of glands and milk ducts, surrounded by fatty tissue which provides its shape and soft form. The elasticity of your skin also contributes to its shape. As you know, certain factors such as age and pregnancy can affect the elasticity of your skin and breast tissue, which results in changes to shape and appearance.
Breast implants can be placed in two general locations, known as submuscular and subglandular placement. Submuscular placement refers to an implant that is placed partially or completely beneath the pectoralis muscle, against the chest wall. In contrast, subglandular placement refers to an implant that is placed beneath the breast tissue, but above the pectoralis muscle. Your surgeon will help determine the implant placement that is best for you.
Breast augmentation procedures typically last approximately one to two hours. Prior to the start of your procedure the treatment area will be thoroughly cleansed and an anesthetic will be administered. Depending on the surgeon’s preferences and the nature of the procedure, a local anesthetic in combination with intravenous sedation or general anesthesia will be used.
The inframammary incision is placed along the crease of the lower portion of the breast. A single, small incision is made along each breast. Using an instrument known as a retractor, the surgeon will open the incision in order to gain better access to the breast tissue below. Although the incision will be made as inconspicuously as possible, its length and appearance may vary depending on the type and size of implant, your body contours, and the surgeon’s preference.
The surgeon will carefully separate the breast tissue with a minimally invasive cautery device and a scalpel, in order to reach the area of the breast in which the pocket will be formed. Using an instrument known as an elevator and their fingers, the surgeon will carefully create a pocket in which to place the breast implant.
Unlike saline implants, which are usually inserted empty, silicone implants are pre-filled. As silicone implants are pre-filled, they generally require a slightly larger incision than saline implants. The surgeon will insert the implant into the pocket and visually inspect your breasts to ensure that they are symmetric. They may adjust the pocket and the position of the breast implant itself to ensure that the desired look is achieved.
The incisions will be closed using sutures in the breast tissue. Sutures, skin adhesive or surgical tape may be used to close the skin. Your surgeon may choose to use non-dissolving sutures, which will be removed in seven to ten days. The scars from the incisions will fade slowly over several months, but it may take up to a year for them to refine completely. As with any surgery, you will most likely experience some pain and swelling after surgery. The majority of the swelling will likely subside within a few days. However, some swelling may persist for several weeks.
Your physician may place you in a special bra or compression garment to aid in the healing process. Compression garments provide support and comfort, minimize swelling, and help to maintain the position of the implants. This is why it is important that you wear the compression garment as recommended by your physician.
You will most likely be able to return to work within three to seven days after your procedure. However, it is important that you avoid any strenuous activity and lifting for approximately three to four weeks. Doing so may delay healing and could damage the implants. You will be able to notice the final results from your procedure once the implants have settled and the swelling has subsided completely.
It is important to realize that your breasts will continue to change shape over time. However, the results from breast augmentation are typically long-lasting, which means that your breasts will maintain the fuller, shapelier appearance that you desire for years to come.
More Porto Alegre info...
Porto Alegre Mid-range
Dado Tambor: Av. T?lio de Rose , 100
Le Bistrot: on winter try the excellent soups. But don´t miss the "nuttela cr?pe". Fernando Gomes, 58 - Phone: 3346-3812
Bistr? Torta de Sorvete: For taking a snack in the afternoon. Try the delicious and famous ice cream pie, the one that give its name to the house. Padre Cahgas, 217 - Phone: 3346-1616 -
Porto Alegre By car
Porto Alegre is served by two major highways: BR-116, crossing it North-South and BR-290, crossing it East-West. The first can be used to visit destinations like Gramado and Canela (both North); the latter gives access to/from Rio Grande do Sul's litoral (East) and to/from Argentina (West).
Be advised that some of these roads are dangerous, for they have poor signaling/conditions and lots of trucks. Keep your travels by car on these roads to the duplicated ones and, if possible, during the day.
-
Plastic Surgery News...
- According to research published in Arthritis and Research Therapy (free full text available at the above link), prolonged use of disease-modifying antirheumatic drugs (DMARDs) and biological therapies may reduce the risk of cardiovascular (CV) disease in patients with rheumatoid arthritis (RA).
The authors used data collected as part of QUEST-RA (The Questionnaires in Standard Monitoring of Patients with Rheumatoid Arthritis Program) to look at the prevalence of CV disease amongst non-selected RA outpatients and the relationship between this, clinical features of RA and the use of DMARDs. By October 2006, the QUEST-RA project had enrolled 4,363 patients; the majority were female (78%) and Caucasian (90%).
The prevalence for lifetime CV events in the entire sample was 3.2% for myocardial infarction, 1.9% for stroke, and 9.3% for any CV event (although there was considerable variation between different countries). A third (33%) of patients had hypertension; other traditional risk factors included hyperlipidaemia (14%), diabetes (8%), history of smoking (43%) and obesity (18%). After adjusting for traditional risk factors and countries, the authors found that prolonged exposure to methotrexate (HR 0.85; 95% CI 0.81 to 0.89), leflunomide (HR 0.59; 95% CI 0.43 to 0.79), sulfasalazine (HR 0.92; 95% CI 0.87 to 0.98), glucocorticoids (HR 0.95; 95% CI 0.92 to 0.98), and biologic agents (HR 0.42; 95% CI 0.21 to 0.81; P <0.05) was associated with a reduction in the risk of CV morbidity.
The authors discuss their findings and the limitations to their study; please see the link above for further details.
- Commenting on the Department of Health's announcement on the new national vascular risk screening programme, Sue Sharpe, CEO, PSNC said: "We are very pleased that the government is committed to developing community pharmacy's role in tackling vascular disease.